2017
DOI: 10.1016/j.athoracsur.2016.10.077
|View full text |Cite
|
Sign up to set email alerts
|

A Novel Murine Model of Marfan Syndrome Accelerates Aortopathy and Cardiomyopathy

Abstract: Background Marfan syndrome (MFS) represents a genetic disorder with variable phenotypic expression. The main cardiovascular sequelae of MFS include aortic aneurysm/dissection and cardiomyopathy. While significant advances in the understanding of TGF-β signaling have led to promising therapeutic targets for the treatment of aortopathy, clinical studies have tempered this optimism. In particular, these studies suggest additional signaling pathways that play a significant role in disease progression. To date, stu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 35 publications
0
11
0
Order By: Relevance
“…In addition, the angiotensin-converting enzyme (ACE) inhibitor enalapril, which blocks AngII formation, did not adequately inhibit aneurysm formation, regardless of the same antihypertensive effect as losartan [ 40 ]. Furthermore, Cavanaugh et al reported that subpressor doses of AngII could accelerate aneurysmal formation and dissection in Fbn1 C1039G/+ mice [ 41 ]. These observations suggested that losartan may exert favorable effects via activating or preserving AT 2 R signal cascades.…”
Section: Marfan Syndromementioning
confidence: 99%
“…In addition, the angiotensin-converting enzyme (ACE) inhibitor enalapril, which blocks AngII formation, did not adequately inhibit aneurysm formation, regardless of the same antihypertensive effect as losartan [ 40 ]. Furthermore, Cavanaugh et al reported that subpressor doses of AngII could accelerate aneurysmal formation and dissection in Fbn1 C1039G/+ mice [ 41 ]. These observations suggested that losartan may exert favorable effects via activating or preserving AT 2 R signal cascades.…”
Section: Marfan Syndromementioning
confidence: 99%
“…Mild LV dilatation, independent of valvular dysfunction, was also observed by Campens et al [ 11 ] in the same mouse model using ultrasound analysis. In other studies by Cavanaugh et al [ 20 ] and Rouf et al [ 21 ], a significant increase in the LV diameter of Fbn1 C1039G/+ mice was only observed after a two-week angiotensin II treatment, or after surgical constriction of the thoracic aorta, respectively. Cook et al [ 22 ], on the other hand, identified a severe primary dilated cardiomyopathy with significant systolic dysfunction in the Fbn1 mgR/mgR mouse model.…”
Section: Introductionmentioning
confidence: 75%
“…Likewise, they support the hypothesis previously reported that the canonical TGF-β signaling contributes to this load-induced cardiac decompensation 16 . An interesting novel in vivo mouse model of Cavanaugh et al consisting of subcutaneously delivered angiotensin II in MFS mice causes accelerated aortic aneurysm formation and dilated cardiomyopathy even without aortic insufficiency, suggesting a potential intrinsic aetiology for the diseased myocardium 21 .…”
Section: Discussionmentioning
confidence: 99%